Pharmacogenomi cs Technology (Theranostics
& CDx) Market
Pharmacogenomics Technology (Theranostics & CDx) Market Scope: Industry Analysis, Market Size, Growth, Trends Till 2031
Request Sample Report
Pharmacogenomics Technology (Theranostics & CDx)
Market Size and Growth
The pharmacogenomics technology market is witnessing significant growth due to advancements in personalized medicine. Theranostics and companion diagnostics (CDx) are driving market expansion, with a projected market size of $7.1 billion by 2027. Increasing demand for precision medicine and targeted therapies is propelling market growth.
Request Sample Report
Companies Covered
(Covid 19 Impact Covered)
◍ Illumina
◍ Roche
◍ Agilent
◍ Abbott
◍ Thermofisher
◍ Qiagen
◍ Guardant Health
◍ MGI Tech Co., Ltd.
◍ Amoydx Biology
◍ Genomics
The Pharmacogenomics Technology (Theranostics & CDx) Market is competitive with key players such as Illumina, Roche, Agilent, Abbott, Thermo Fisher, Qiagen, Guardant Health, MGI Tech Co., Ltd., Amoydx Biology, and Genomics. These companies offer advanced genomic testing services for personalized medicine, leading to market growth.
- Illumina: $3.33 billion in sales revenue
- Roche: $58.82 billion in sales revenue
- Agilent: $5.34 billion in sales revenue
Request Sample Report
Market Segmentation
By Application
Tumor
Diabetes
Mental Diseases
Cardiovascular Diseases
Others
Request Sample Report
By Product
Instrument
Reagents and Consumables
Others
◍
◍
◍
◍
◍
◍
◍
◍
Market Growth
Request Sample Report
$ X Billion USD
THANK YOU Email : sales@reportprime.com USA : +1 507 500 7209 Website : https://www.reportprime.com/ Request Sample Report Contact US Our Clients